Clinical Trial Update: The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of OPC-64005 for adult ADHD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention-deficit Hyperactivity Disorder in Adults

Drugs mentioned

• OPC-64005

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Adult Attention Deficit Hyperactivity Disorder | Phase 2 | Status: COMPLETED | Results posted: 2021-10-29